Literature DB >> 3141289

Activation of mouse peritoneal macrophages in vitro or in vivo by recombinant murine gamma interferon inhibits the growth of Chlamydia trachomatis serovar L1.

G M Zhong1, L M de la Maza.   

Abstract

Peritoneal mouse macrophages activated in vitro with recombinant murine gamma interferon (10 ng/ml) or in vivo (10 micrograms per mouse) showed a significant decrease in the growth and yield of Chlamydia trachomatis. The restriction of the growth of C. trachomatis paralleled the expression of Iad on the macrophages. Mice that received macrophages activated in vitro with recombinant murine gamma interferon showed a significant decrease in the yield of chlamydial infection-forming units from their spleens and peritoneal fluids.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3141289      PMCID： PMC259745          DOI： 10.1128/iai.56.12.3322-3325.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  17 in total

1.  Growth of meningopneumonitis virus in normal and immune guinea pig monocytes.

Authors:  A A BENEDICT; C McFARLAND
Journal:  Nature       Date:  1958-06-21       Impact factor: 49.962

2.  Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages.

Authors:  C D Rothermel; B Y Rubin; E A Jaffe; H W Murray
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

3.  Colony formation by mouse peritoneal exudate cells in vitro.

Authors:  H Lin; C C Stewart
Journal:  Nat New Biol       Date:  1973-06-06

4.  Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication.

Authors:  C D Rothermel; B Y Rubin; H W Murray
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

5.  Effect of IFN-gamma on the immune response in vivo and on gene expression in vitro.

Authors:  M Nakamura; T Manser; G D Pearson; M J Daley; M L Gefter
Journal:  Nature       Date:  1984 Jan 26-Feb 1       Impact factor: 49.962

6.  Association of an inflammatory I region-associated antigen-positive macrophage influx and genetic resistance of inbred mice to Rickettsia tsutsugamushi.

Authors:  T R Jerrells
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

7.  Inhibition of Chlamydia psittaci in oxidatively active thioglycolate-elicited macrophages: distinction between lymphokine-mediated oxygen-dependent and oxygen-independent macrophage activation.

Authors:  G I Byrne; C L Faubion
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

8.  Fate of Chlamydia trachomatis in human monocytes and monocyte-derived macrophages.

Authors:  E Manor; I Sarov
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

9.  Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.

Authors:  H W Murray; G L Spitalny; C F Nathan
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.

Authors:  P S Steeg; R N Moore; H M Johnson; J J Oppenheim
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307
View more
  17 in total

1.  Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease.

Authors:  D C Mabey; R L Bailey; D Dunn; D Jones; J H Williams; H C Whittle; M E Ward
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

Review 2.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

Review 3.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

4.  Role of Nramp1 deletion in Chlamydia infection in mice.

Authors:  S Pal; E M Peterson; L M de La Maza
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  Chlamydia trachomatis-specific human CD8+ T cells show two patterns of antigen recognition.

Authors:  Malgosia K Matyszak; J S Hill Gaston
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  Inhibition of Ehrlichia risticii infection in murine peritoneal macrophages by gamma interferon, a calcium ionophore, and concanavalin A.

Authors:  J Park; Y Rikihisa
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

7.  Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection.

Authors:  Wen Cheng; Pooja Shivshankar; Zhongyu Li; Lili Chen; I-Tien Yeh; Guangming Zhong
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

8.  Distinct roles of CD28- and CD40 ligand-mediated costimulation in the development of protective immunity and pathology during Chlamydia muridarum urogenital infection in mice.

Authors:  Lili Chen; Wen Cheng; Pooja Shivshankar; Lei Lei; Xiaoyun Zhang; Yimou Wu; I-Tien Yeh; Guangming Zhong
Journal:  Infect Immun       Date:  2009-04-27       Impact factor: 3.441

9.  Protection against Chlamydia psittaci in mice conferred by Lyt-2+ T cells.

Authors:  D Buzoni-Gatel; L Guilloteau; F Bernard; S Bernard; T Chardès; A Rocca
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

10.  Coxiella burnetii-Infected NK Cells Release Infectious Bacteria by Degranulation.

Authors:  Svea Matthiesen; Luca Zaeck; Kati Franzke; Rico Jahnke; Charlie Fricke; Michael Mauermeir; Stefan Finke; Anja Lührmann; Michael R Knittler
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.